Published: Fri, November 03, 2017
Medicine | By Earnest Bishop

FDA Issues Warning To CBD Companies

FDA Issues Warning To CBD Companies

"We have an obligation to provide caregivers and patients with the confidence that drugs making cancer treatment claims have been carefully evaluated for safety, efficacy, and quality, and are monitored by the FDA once they're on the market", FDA Commissioner Scott Gottlieb writes in the statement.

Marijuana doesn't cure cancer.

'Selling these unapproved products with unsubstantiated therapeutic claims is not only a violation of the Federal Food, Drug and Cosmetic Act, but also can put patients at risk as these products have not been proven to be safe or effective.

Although claims vary from product to product, the FDA says fraudulent cancer products "often use a particular vocabulary".

The FDA particularly is cracking down upon products sold as cures for cancer but actually containing cannabidiol (CBD) that is obtained from cannabis or marijuana.

While cannabidiol is being tested by medical researchers as a possible treatment for epilepsy, it has not been approved by the FDA for use in any drug product.

CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, teas, and topical lotions and creams.

Clovis, Linked to Mueller Probe, Withdraws Nomination for USDA Top Scientist Post
A former Trump campaign aide withdrew from consideration to be the top scientist at the U.S. In a letter to Clovis sent in mid-October, Sen.

"Substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors", Gottlieb said.

When issuing warning letters about other "illegal" cancer treatments in April, the FDA said consumers should not use them "because they may be unsafe and could prevent a person from seeking an appropriate and potentially life-saving cancer diagnosis or treatment", according to Douglas W. Stearn, director of the FDA's Office of Enforcement and Import Operations."We encourage people to remain vigilant whether online or in a store, and avoid purchasing products marketed to treat cancer without any proof they will work". Another product from Greenroads Health claimed that "CBD [has] anti-proliferative properties that inhibit cell division and growth in certain types of cancer, not allowing the tumor to grow" and could treat "asthma, Alzheimer's disease, arthritis, autism, bipolar disorder and various types of cancer". Marketing and Consulting and Stanley Brothers Social Enterprises.

The FDA said that companies promoting CBD products with health claims could affect the marijuana industry. These pages contain the unsubstantiated bogus claims about these drugs.

The companies were likely basing their health claims on a small number of animal and cell studies suggesting that CBD and other marijuana components may be able to damage or kill cancer cells.

CW Hemp, which makes a cannabinoid product called Charlotte's Web, has received extensive media coverage, including from NBC News, for some of its products, but the FDA says it's gone too far with some of its claims for its dietary supplement products.

Beyond a complete lack of data showing the products work in humans, the FDA also notes that there is no data on proper dosages or how they may interact with other drugs. The FDA is responsible for regulating the manufacturing, marketing, and distribution of foods and drugs. These spurious products have not undergone any of these regulatory processes that make them safe for use. Information online about the products included dosing instructions and testimonials which the agency claimed established that the company's intention that the products were to be used like a medication.

Like this: